Guided Therapeutics (GTHP) Change in Accured Expenses (2016 - 2025)
Guided Therapeutics' Change in Accured Expenses history spans 15 years, with the latest figure at $832000.0 for Q4 2025.
- On a quarterly basis, Change in Accured Expenses rose 433.33% to $832000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 150.09% increase, with the full-year FY2025 number at $1.4 million, up 150.09% from a year prior.
- Change in Accured Expenses hit $832000.0 in Q4 2025 for Guided Therapeutics, up from $204000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for GTHP hit a ceiling of $832000.0 in Q4 2025 and a floor of -$450000.0 in Q3 2021.
- Historically, Change in Accured Expenses has averaged $110450.0 across 5 years, with a median of $75000.0 in 2022.
- Biggest five-year swings in Change in Accured Expenses: tumbled 454.33% in 2021 and later surged 2009.52% in 2024.
- Tracing GTHP's Change in Accured Expenses over 5 years: stood at $571000.0 in 2021, then tumbled by 77.41% to $129000.0 in 2022, then skyrocketed by 34.11% to $173000.0 in 2023, then fell by 9.83% to $156000.0 in 2024, then surged by 433.33% to $832000.0 in 2025.
- Business Quant data shows Change in Accured Expenses for GTHP at $832000.0 in Q4 2025, $204000.0 in Q3 2025, and $221000.0 in Q2 2025.